Correlation Engine 2.0
Clear Search sequence regions

  • drug design (3)
  • humans (1)
  • nucleosides (2)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    The fundamental aim of drug design in research and development is to invent molecules with selective affinity towards desired disease-associated targets. At the atomic loci of binding surfaces, systematic structural variations can define affinities between drug candidates and biomolecules, and thereby guide the optimization of safety, efficacy and pharmacologic properties. Hydrophobic interaction between biomolecules and drugs is integral to binding affinity and specificity. Examples of antiviral drug discovery are discussed.


    Lillian L Lou, John C Martin. Selected Thoughts on Hydrophobicity in Drug Design. Molecules (Basel, Switzerland). 2021 Feb 07;26(4)

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 33562230

    View Full Text